• Aging and Sex
  • For men
    • Multi Vitamin for Him CPA
    • Practical Tips to Maintain Sexual Virility
    • ProSolution Plus is a Natural Remedy For Premature Ejaculation
  • for women
    • Breast Actives CPA
    • Four Ways To Look Young
    • Ten Ways to Look Like a Model Bride
  • Home Based Business
    • AWESOME EASY CASH MONEY TO YOU TODAY!
    • Craft Idea for a Group: Make a Mural
    • DIGISOFT PAYLINE How to Make Instant Money Now DIGISOFT PAYLINE
    • Getting Your Family Involved In Your Home Business
    • Home Based Real Estate Investing
    • Home Based Real Estate Investing
    • How To Become A Work At Home Mom
    • How to Get Free Rent
    • Make Extra Cash & Work From Home!
    • Strategies for Success in the Exciting and Lucrative Home-Based Business of Jewelry & Gemstones
    • THE INTERNATIONAL PROJECT OF THE 21st CENTURY
    • WIN FREE DOGECOINS EVERY HOUR!
  • How you can Regain your Youthful Appearance without Expensive Treatments or Surgery!
  • Intelligent nutritional supplements
    • Antioxidants Nutrients Have Powerful Anti-Cancer Activity!
    • AsthmaMist CPA
    • What Are Phytoceramides?
    • Cleanse the Body, Curb Unhealthy Cravings, and Lose Weight with ProShape Rx
  • interesting idea, hobby
    • Christmas Craft: Bead and Pipe Cleaner Ornaments
    • Wedding Crafts Ideas for Saving Money
  • Natural products for weight loss
    • Natural Weight Loss Products
  • Privacy Policy
  • Terms And Conditions

Health and Beauty

The site is about the beauty and health of men, women, children

  • Home

Enter your email address:

Spam Blocked

18,994 spam blocked by Akismet

Supercomputers Assist Doctors to Search Better Cancer Drugs

  • Interesting Facts

Surgery and radiation remove, kill, or damage cancer cells in a certain area. But chemotherapy – which uses medicines or drugs to treat cancer – can work throughout the whole body, killing cancer cells that have spread far from the original tumor.

Finding new drugs that can more effectively kill cancer cells or disrupt the growth of tumors is one way to improve survival rates for ailing patients.‘Finding new drugs that can more effectively kill cancer cells or disrupt the growth of tumors is one way to improve survival rates for ailing patients.’

Increasingly, researchers looking to uncover and test new drugs use powerful supercomputers like those developed and deployed by the Texas Advanced Computing Center (TACC).

“Advanced computing is a cornerstone of drug design and the theoretical testing of drugs,” said Matt Vaughn, TACC’s Director of Life Science Computing. “The sheer number of potential combinations that can be screened in parallel before you ever go in the laboratory makes resources like those at TACC invaluable for cancer research.”

Three projects powered by TACC supercomputer, which use virtual screening, molecular modeling and evolutionary analyses, respectively, to explore chemotherapeutic compounds, exemplify the type of cancer research advanced computing enables.

VIRTUAL SCREENING

Shuxing Zhang, a researcher in the Department of Experimental Therapeutics at the University of Texas MD Anderson Cancer Center, leads a lab dedicated to computer-assisted rational drug design and discovery of novel targeted therapeutic agents.

The group develops new computational methods, using artificial intelligence and high-performance computing-based virtual screening strategies, that help the entire field of cancer drug discovery and development.

Identifying a new drug by intuition or trial and error is expensive and time consuming. Virtual screening, on the other hand, uses computer simulations to explore how a large number of small molecule compounds “dock”, or bind, to a target to determine if they may be candidates for future drugs.

“In silico virtual screening is an invaluable tool in the early stages of drug discovery,” said Joe Allen, a research associate at TACC. “It paints a clear picture not only of what types of molecules may bind to a receptor, but also what types of molecules would not bind, saving a lot of time in the lab.”

One specific biological target that Zhang’s group investigates is called TNIK (TRAF2- and NCK-interacting kinase). TNIK is an enzyme that plays a key role in cell signaling related to colon cancer. Silencing TNIK, it is believed, may suppress the proliferation of colorectal cancer cells.

Writing in Scientific Reports in September 2016, Zhang and his collaborators reported the results of a study that investigated known compounds with desirable properties that might act as TNIK inhibitors.

Using the Lonestar supercomputer at TACC, they screened 1,448 Food and Drug Administration-approved small molecule drugs to determine which had the molecular features needed to bind and inhibit TNIK.

They discovered that one — mebendazole, an approved drug that fights parasites — could effectively bind to the target. After testing it experimentally, they further found that the drug could also selectively inhibit TNIK’s enzymatic activity.

As an FDA-approved drug that can be used at higher dosages without severe side effects, mebendazole may is a strong candidate for further exploration and may even exhibit a ‘synergic anti-tumor effect’ when used with other anti-cancer drugs.

“Such advantages render the possibility of quickly translating the discovery into a clinical setting for cancer treatment in the near future,” Zhang and his collaborators wrote.

In separate research published in Cell in 2013, Zhang’s group used Lonestar to virtually screen an even greater number of novel inhibitors of Skp2, a critical oncogene that controls the cell cycle and is frequently observed as being overexpressed in human cancer.

“Molecular docking is a computationally-expensive process and the screening of 3 million drug-like compounds needs more than 2,000 days on a single CPU [computer processing unit],” Zhang said. “By running the process on a high-performance computing cluster, we were able to screen millions of compounds within days instead of years.”

Their computational approaches identified a specific Skp2 inhibitor that can selectively impair Skp2 activity and functions, thereby exhibiting potent anti-tumor activity.

“Our work at TACC has resulted in multiple potential drug candidates currently at the different stages of preclinical and clinical studies,” said Zhang. “We hope to continue using the resources to identify more effective and less toxic therapeutics.”

MOLECULAR MODELING

Described as “the guardian of the genome”, tumor protein 53 (p53) plays a crucial role in multicellular organisms, conserving the stability of DNA by preventing mutations and thereby acting as a tumor suppressor.

However, in approximately 50 percent of all human cancers, p53 is mutated and rendered inactive. Therefore, reactivation of mutant p53 using small molecules has been a long-sought-after anticancer therapeutic strategy.

Rommie Amaro, professor of Chemistry and Biochemistry at the University of California, San Diego has been studying this important molecule for years trying to understand how it works.

In September 2016, writing in the journal Oncogene, she reported results from the largest atomic-level simulation of the tumor suppression protein to date — comprising more than 1.5 million atoms.

The simulations helped to identify new “pockets” — binding sites on the surface of the protein — where it may be possible to insert a small molecule that could reactivate p53. They revealed a level of complexity that is very difficult, if not impossible, to experimentally test.

“We could see how when the full-length p53 was bound to a DNA sequence that was a recognition sequence, the tetramer clamps down and grips onto the DNA – which was unexpected,” Amaro said.

In contrast, with the negative control DNA, p53 stays more open. “It actually relaxes and loosens its grip on the DNA,” she said. “It suggested a mechanism by which this molecule could actually change its dynamics depending on the exact sequence of DNA.”

According to Amaro, computing provides a better understanding of cancer mechanisms and ways to develop possible novel therapeutic avenues.

“When most people think about cancer research they probably don’t think about computers, but biophysical models are getting to the point where they have a great impact on the science,” she said.

EVOLUTIONARY COMPARISONS

Chemicals created by plants are the basis for the majority of the medicines used today. One such plant, the periwinkle (Catharanthus roseus), is used in chemotherapy protocols for leukemia and Hodgkin’s lymphoma.

A completely different approach to drug discovery involves studying the evolution of plants that are known to be effective chemotherapeutic agents and their genetic relatives, since plants that share an evolutionary history often share related collections of chemical compounds.

University of Texas researchers — working with researchers from King Abdulaziz University in Saudi Arabia, the University of Ottawa and Université de Montréal — have been studying Rhazya stricta, an environmentally stressed, poisonous evergreen shrub found in Saudi Arabia that is a member of the family that includes the periwinkle.

To understand the genome and evolutionary history of Rhayza stricta, the researchers performed genome assemblies and analyses on TACC’s Lonestar, Stampede and Wrangler systems. According Robert Jansen, professor of Integrative Biology at UT and lead researcher on the project, the computational resources at TACC were essential for constructing and studying the plant’s genome.

The results were published in Scientific Reports in September 2016.

“These analyses allowed the identification of genes involved in the monoterpene indole alkaloid pathway, and in some cases expansions of gene families were detected,” he said.

The monoterpene indole alkaloid pathway produces compounds that have known therapeutic properties against cancer.

From the annotated Rhazya genome, the researchers developed a metabolic pathway database, RhaCyc, that can serve as a community resource and help identify new chemotherapeutic molecules.

Jansen and his team hope that by better characterizing the genome and evolutionary history using advanced computational methods, and making the metabolic pathway database available as a community resource, they can speed the development of new medicines in the future.

“There are a nearly infinite number of possible drug compounds,” Vaughn said. “But knowing the principles of what a good drug might look like – how it might bind to a certain pocket or what it might need to resemble – helps narrow the scope immensely, accelerating discoveries, while reducing costs.”

Source: Eurekalert

 

May 3, 2017 admin

Post navigation

Untreatable Diseases Can Now Be Cured With Stem Cells → ← House Delays Vote on Obamacare Overhaul

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Genital Warts Natural and Alternative Treatment Remedies 1,695 views
  • ‘Love Hormone’ Oxytocin May Enhance Feelings Of Spirituality 942 views
  • Ginseng: Root of Immortality 843 views
  • WIN FREE DOGECOINS EVERY HOUR! 828 views
  • Get Rid of Cellulite, Once and For All! 695 views
  • THE INTERNATIONAL PROJECT OF THE 21st CENTURY 687 views
  • Breast Actives CPA 659 views
  • Make Extra Cash & Work From Home! 606 views

Popular articles

  • Genital Warts Natural and Alternative Treatment Remedies 1,695 views | under alternative medetsina
  • ‘Love Hormone’ Oxytocin May Enhance Feelings Of Spirituality 942 views | under alternative medetsina
  • Ginseng: Root of Immortality 843 views | under alternative medetsina
  • WIN FREE DOGECOINS EVERY HOUR! 828 views
  • Get Rid of Cellulite, Once and For All! 695 views | under Body Health
  • THE INTERNATIONAL PROJECT OF THE 21st CENTURY 687 views
  • Breast Actives CPA 659 views
  • Make Extra Cash & Work From Home! 606 views
Buy Brand Drugs

Archives

Powered by WordPress | theme SG Double